Efficacy of treatment in MDR and XDR lung TB patients in the follow-up period with the use of new anti-tuberculosis agent

A. Starshinova (St.-Petersburg, Russian Federation), E. Beliaeva (St.-Petersburg, Russian Federation), M. Nazarenko (St.-Petersburg, Russian Federation), M. Pavlova (St.-Petersburg, Russian Federation), I. Chernochaeva (St.-Petersburg, Russian Federation), P. Yablonskiy (St.-Petersburg, Russian Federation)

Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Session: Extra-pulmonary tuberculosis and comorbidities
Session type: Thematic Poster
Number: 3001

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Starshinova (St.-Petersburg, Russian Federation), E. Beliaeva (St.-Petersburg, Russian Federation), M. Nazarenko (St.-Petersburg, Russian Federation), M. Pavlova (St.-Petersburg, Russian Federation), I. Chernochaeva (St.-Petersburg, Russian Federation), P. Yablonskiy (St.-Petersburg, Russian Federation). Efficacy of treatment in MDR and XDR lung TB patients in the follow-up period with the use of new anti-tuberculosis agent. 3001

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: